Name: Divakar Ramakrishnan
New title: Chief research and development officer, Insulet
Previous title: Chief science, innovation and quality officer, Convatec
Insulet hired Divakar Ramakrishnan as its first chief research and development officer, the company confirmed on Monday. Ramakrishnan will lead global product development and Insulet’s research and development as it faces growing competition from other insulin pump makers.
“This is an important milestone in our efforts to strengthen Insulet’s innovation capabilities in support of accelerating our exciting pipeline to reach even more people with diabetes around the world,” an Insulet spokesperson wrote in an emailed statement.
Ramakrishnan announced the new job in a Monday LinkedIn post, adding that the strength of Insulet’s product portfolio and pipeline drew him to the role.
Ramakrishnan’s background includes working at medical device firm Convatec as chief science, innovation and quality officer, according to his LinkedIn profile. Prior to working for Convatec, Ramakrishnan was chief digital officer at Eli Lilly.
Insulet, which makes insulin patch pumps for managing diabetes, is developing new technologies as rival companies work on competing products. At a recent diabetes conference, Insulet shared pivotal data on its next patch pump, the Omnipod 6, and a fully closed loop automated insulin delivery system for people with Type 2 diabetes, which requires no carbohydrate counting or pre-meal boluses.
